Disseminated herpes zoster infection in a patient with lymphoma

被引:2
作者
Kurtaran, Behice [1 ]
Paydas, Semra [2 ]
Candevir, Aslihan [1 ]
Komur, Sueheyla [1 ]
Aksu, Hasan Salih Zeki [1 ]
机构
[1] Cukurova Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Adana, Turkey
[2] Cukurova Univ, Fac Med, Dept Med Oncol, Adana, Turkey
关键词
Acyclovir; disseminated; herpes zoster; resistance; immunosuppression; VZV; SIMPLEX-VIRUS-RESISTANCE; NON-HODGKINS-LYMPHOMA; ACYCLOVIR RESISTANCE; PENCICLOVIR; THERAPY; STRAIN;
D O I
10.3906/sag-0803-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immunosuppression facilitates varicella zoster virus (VZV) reactivation in immunocompromised patients. Atypical presentation Such as disseminated disease of herpes zoster infection has been described in immunosuppressed patients. One of the best choices of therapy in herpes zoster infection is acyclovir, but long-term therapy may cause resistance to it. ILL this report a disseminated herpes zoster infection is described in a patient with T cell lymphoma after acyclovir/valacyclovir therapy. The infection was irresponsive to acyclovir and valacyclovir and we were unable to control the infection because it was not possible to obtain foscarnet and the patient died due to Staphylococcus epidermis sepsis.
引用
收藏
页码:479 / 482
页数:4
相关论文
共 11 条
[1]   In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir? [J].
Andrei, G ;
De Clercq, E ;
Snoeck, R .
ANTIVIRAL RESEARCH, 2004, 61 (03) :181-187
[2]   Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy [J].
Bacon, TH ;
Levin, MJ ;
Leary, JJ ;
Sarisky, RT ;
Sutton, D .
CLINICAL MICROBIOLOGY REVIEWS, 2003, 16 (01) :114-+
[3]  
CROWE J, 2007, BRIT J HAEMATOL, V138, P406
[4]   Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma [J].
Ladetto, M ;
Zallio, F ;
Vallet, S ;
Ricca, I ;
Cuttica, A ;
Caracciolo, D ;
Corradini, P ;
Astolfi, M ;
Sametti, S ;
Volpato, F ;
Bondesan, P ;
Vitolo, U ;
Boccadoro, M ;
Pileri, A ;
Gianni, AM ;
Tarella, C .
LEUKEMIA, 2001, 15 (12) :1941-1949
[5]  
Lesueur A, 1998, ANN DERMATOL VENER, V125, P127
[6]   Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells [J].
Levy, O ;
Orange, JS ;
Hibberd, P ;
Steinberg, S ;
LaRussa, P ;
Weinberg, A ;
Wilson, SB ;
Shaulov, A ;
Fleisher, G ;
Geha, RS ;
Bonilla, FA ;
Exley, M .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (07) :948-953
[7]   A retrospective, case-control study of acyclovir resistance in herpes simplex virus [J].
Malvy, D ;
Treilhaud, M ;
Bouée, S ;
Crochard, A ;
Vallée, D ;
El Hasnaoui, A ;
Aymard, M .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (03) :320-326
[8]   CONTINUOUS VARICELLA-ZOSTER INFECTION ASSOCIATED WITH ACYCLOVIR RESISTANCE IN A CHILD WITH AIDS [J].
PAHWA, S ;
BIRON, K ;
LIM, W ;
SWENSON, P ;
KAPLAN, MH ;
SADICK, N ;
PAHWA, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (19) :2879-2882
[9]  
POTTAGE JC, 1995, INFECT AGENT DIS, V4, P115
[10]  
WHITLEY R, 2005, PRINCIPLES PRACTICE, V2, P1780